Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Operating Margin (2016 - 2025)

Editas Medicine (EDIT) has disclosed Operating Margin for 11 consecutive years, with 325.44% as the latest value for Q3 2025.

  • Quarterly Operating Margin rose 10732374.0% to 325.44% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 428.71% through Sep 2025, down 5869.0% year-over-year, with the annual reading at 777.22% for FY2024, 56067.0% down from the prior year.
  • Operating Margin for Q3 2025 was 325.44% at Editas Medicine, up from 1440.58% in the prior quarter.
  • The five-year high for Operating Margin was 39.9% in Q4 2023, with the low at 136952.38% in Q3 2022.
  • Average Operating Margin over 5 years is 17008.0%, with a median of 970.72% recorded in 2022.
  • The sharpest move saw Operating Margin soared 13601229bps in 2023, then plummeted -10670909bps in 2024.
  • Over 5 years, Operating Margin stood at 14617.68% in 2021, then soared by 93bps to 970.72% in 2022, then skyrocketed by 96bps to 39.9% in 2023, then crashed by -282bps to 152.24% in 2024, then tumbled by -114bps to 325.44% in 2025.
  • According to Business Quant data, Operating Margin over the past three periods came in at 325.44%, 1440.58%, and 1635.1% for Q3 2025, Q2 2025, and Q1 2025 respectively.